Skip to content

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2026, titled “Glenmark Pharmaceuticals Launches GLIPIQ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment… 

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325. |SUBJECT: Press Release

IRB INFRASTRUCTURE TRUST

IRB INFRASTRUCTURE TRUST has informed the Exchange ‘Update regarding Financial Closure achieved for TOT-18 Project’. |SUBJECT: Updates

Oberoi Realty Limited

OBEROI REALTY LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL |SUBJECT: Update-Acquisition/Scheme/Sale/Disposal-XBRL

TIL Limited

TIL Limited has informed the Exchange regarding its upcoming Right Issue. |SUBJECT: Committee Meeting Updates